Saphnelo 300 MG/2 ML vial 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F4E3U
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $37,903
Award facts
- Contract value 100% obligated
- $37,902.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $37,902.70 to AmerisourceBergen Drug Corp for the supply of SAPHNELO (anifrolumab) 300 mg/2 mL vials on a firm fixed-price basis. The contract, issued on January 5, 2026, with an ultimate completion date of January 27, 2026, represents a non-competitive delivery order under DLA's existing procurement framework. SAPHNELO is a monoclonal antibody used in the treatment of systemic lupus erythematosus, reflecting DLA's continued procurement of specialized pharmaceutical therapies to support military and federal healthcare systems. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will fulfill performance at its corporate office location.
This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery/Indefinite Quantity (IDIQ) contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The prime IDIQ vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical commodities globally to support military healthcare programs, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen Drug Corp's position as a major pharmaceutical distributor and federal vendor demonstrates its capability to meet specialized medical procurement requirements through competitive federal contracting processes. No set-aside designation was used for this award.
Quick answers
Who was awarded contract SPE2DR26F4E3U?
SPE2DR26F4E3U was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 5, 2026.
How much is contract SPE2DR26F4E3U worth?
The government has obligated $37,903 on SPE2DR26F4E3U.
Is contract SPE2DR26F4E3U an order under another contract?
Yes. SPE2DR26F4E3U is a delivery order under SPE2DR25D3012, an indefinite delivery contract.
Was contract SPE2DR26F4E3U competed?
The extent of competition for SPE2DR26F4E3U was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award